Clinical fellowship applicants must hold an MD degree or equivalent, and be within five years of completion of specialization OR in training to achieve such specialization (e.g. Fellow, Resident, Registrar, etc.).
Research fellowship applicants may hold either an MD or PhD degree and must be within five years of training completion.
All applicants should have a demonstrated interest in psoriasis.
Research Track Details:
Research fellows will be matched with clinical, translational, or laboratory-based psoriasis research mentors. Fellows are expected to observe and contribute to an active study or co-develop a small-scale research project with their mentor. The program emphasizes flexibility, relationship-building, and foundational research skill development as well as active interaction between research and clinical care to foster long-term collaborations. The on-site visit will last up to 12 weeks, and financial support will be $1,100 per week.
Clinical Track Details:
Clinical fellows will be matched with mentors primarily involved in clinical practice and patient care. Fellows are expected to observe and develop their patient treatment skills. The program emphasizes clinical practice learning and skill development as well as active interaction between clinical care and research. The on-site visit will be for a minimum of two weeks up to four weeks, and financial support will be $1,100 per week.
Both the Research and Clinical Fellowships include:
In-person and Virtual Mentoring
Congress attendance
Other
Awarded fellows receive a stipend to cover the following expenses:
For questions about the IPC International Fellowship Program, please send an email to Fellowship@psoriasiscouncil.org.
SPECIAL NOTE: If AI is used to assist in writing the Personal Statement, ensure it has been adequately reviewed before submission. In addition to covering the points above, it should reflect the applicant’s enthusiasm for developing their skills in psoriasis and reflect the applicant’s unique voice and perspective.
SPECIAL NOTE: Please do not submit a general letter of recommendation. Letters should be written by someone who knows the applicant personally and can specifically speak to their interest in psoriasis, as well as their suitability for this fellowship opportunity.
The application period for the 2027 IPC Fellowship program is now closed. Applications for the 2028 Fellowships will be accepted from September 1 through 30, 2027.
WORKING TOWARDS CONTINUAL PROGRAM IMPROVEMENT IN THE BEST INTERESTS OF THE PAST, PRESENT AND FUTURE IPC INTERNATIONAL FELLOWS
The IPC International Fellowship Program Advisory Committee is comprised of IPC Board Members, Councilors, and Junior Councilors who work to ensure that the further development of IPC’s Fellowship program is in keeping with and in support of IPC’s strategic plan in partnership with the executive team. Together they review, analyze, and generate new ideas to work towards continual program improvement in the best interests of the past, present and future IPC International Fellows.
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.
